Clinical Aspects and Management of Levodopa-Induced Dyskinesia

In Parkinson's disease, one of the most troublesome dilemmas is the treatment of levodopa-induced dyskinesia. After a few years, chronic treatment with levodopa is associated with the development of dyskinesias. Strategies to delay or to reduce dyskinesias are based on the change of levodopa do...

Full description

Saved in:

Bibliographic Details
Published in:	Parkinson's disease Vol. 2012; no. 2012; pp. 560 - 571
Main Authors:	Calabresi, Paolo, Cardaioli, Gabriela, Murasecco, Donatella, Sacchini, Elisa, Marsili, Erica, Simoni, Simone, Tambasco, Nicola, Rossi, Aroldo
Format:	Journal Article
Language:	English
Published:	Cairo, Egypt Hindawi Limiteds 01-01-2012 Hindawi Publishing Corporation Hindawi Limited
Subjects:	Review
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	In Parkinson's disease, one of the most troublesome dilemmas is the treatment of levodopa-induced dyskinesia. After a few years, chronic treatment with levodopa is associated with the development of dyskinesias. Strategies to delay or to reduce dyskinesias are based on the change of levodopa dosing or the early use of dopamine agonists. Dopamine agonists with different pharmacological profile are available. Our paper was aimed to analyse the clinical impact and the management of dyskinesias with dopamine agonists.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Academic Editor: Gilberto Fisone
ISSN:	2042-0080 2090-8083 2042-0080
DOI:	10.1155/2012/745947